Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host Disease

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement